Test Code (รหัสการทดสอบ):
090-70-1415
Order Name (ชื่อการทดสอบ):
SARS-CoV-2/ Influenza A&B/ RSV, Multiplex Real time RT-PCR
Clinical Information (ข้อมูลทางคลินิก):
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first known to infect people in 2019. This virus is a positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). The virus is spread from person to person through droplets released when an infected person coughs, sneezes, or talks. SARS-CoV-2 can cause both upper and lower respiratory tract infection. Symptoms can range from mild to severe in both healthy and immunocompromised patients. The early stages of disease, symptoms maybe nonspecific and resemble other common respiratory tract infections.
Influenza, or the flu, is a contagious viral infection of the respiratory tract. Transmission of influenza is primarily airborne (i.e., coughing or sneezing). Symptoms commonly include fever, chills, headache, muscle aches, malaise, cough, and sinus congestion. Gastrointestinal symptoms (i.e., nausea, vomiting, or diarrhea) may also occur, primarily in children, but are less common in adults. Symptoms generally appear within two days of exposure to an infected person. Pneumonia may develop as a complication of influenza infection, causing increased morbidity and mortality in pediatric, elderly, and immunocompromised populations.
Respiratory syncytial virus (RSV) is the cause of a contagious disease that afflicts primarily infants and the elderly who are immunocompromised. The virus can live for hours on countertops and toys and causes both upper respiratory infections, such as tracheobronchitis and lower respiratory infections manifesting as bronchiolitis and pneumonia.
Reference Value (ค่าอ้างอิง):
SARS-CoV-2 Not detected
Influenza A Virus Not detected
Influenza B Virus Not detected
Respiratory Syncytial Virus (RSV) Not detected
Interpretation (การแปลผล):
1. This assay result should be interpreted with patient history and other diagnostic information to determine patient infection status.
2. Erroneous test results might occur from improper specimen collection, failure to follow the recommended sample collection, handling and storage procedures, technical error, sample mix-up, or because the number of organisms in the specimen is too low to be detected by the test.
3. Negative results do not preclude SARS-CoV-2, influenza virus or RSV infection and should not be used as the sole basis for treatment or other patient management decisions.
4. Viral nucleic acid may persist in vivo, independent of virus viability. Detection of analyte target(s) does not imply that the corresponding virus(es) are infectious or are the causative agents for clinical symptoms.
5. If the virus mutates in the target region SARS-CoV-2, influenza virus and RSV may not be detected or may be detected less predictably.
6. The test is specific for SARS-CoV-2, influenza A, influenza B, and RSV; therefore, the results do not exclude the possibility of infection with other respiratory viruses or bacterial infection.
Clinical Reference (เอกสารอ้างอิง):
Manufacturer’s packages insert, STANDARD™ M10 Flu/RSV/SARS-CoV-2, April 2023, SD Biosensor Inc, Chungcheongbuk-do 28161, Korea